Kasim Kutay (født 13. maj 1965) er den nuværende administrerend... - dofaq.co
Kasim Kutay (født 13. maj 1965) er den nuværende administrerend...Kasim Kutay (født 13. maj 1965) er den nuværende administrerende direktør, CEO, i Novo Holdings A/S[1], et investeringsselskab som administrerer investeringer og aktiver for Novo Nordisk Fonden.
Novo Holdings CEO Kasim Kutay Speaks With Bloomberg in Davos
Kasim Kutay, CEO of Novo Holdings: Catalent purchase marks new era of acquisitions
Novo Nordisk's controlling shareholder plans to invest about $35 bln by 2030
Novo Holdings plans to ramp up dealmaking amid Wegovy windfall: Bloomberg
Novo to use Ozempic and Wegovy windfall to invest $7bn a year by 2030
Big Pharma's Big Problems: Insights From Novo Holdings CEO
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Novo Nordisk owner readies for big Wegovy windfall
Novo Nordisk's controlling shareholder plans to invest up to $7 bln a year by 2030 - FT
The moment the weight-loss drug Wegovy became a big deal
Fill-finish sites will help Novo Nordisk boost Wegovy, Ozempic output - Novo Holdings CEO
Novo Holdings to buy US drug maker Catalent in $16.5bn deal
Novo Nordisk Owner Will Invest Ozempic Profits in Deals in Asia
Novo Nordisk-owner to expand in India this year
Novo to invest share of Wegovy windfall in UK life sciences
Novo Nordisk owner sees IPO window opening
Novo Holdings Going Big In Asia, CEO Talks Investment Plans
Novo Holder Boosts Investments With $7 Billion Goal, FT Reports
Novo Nordisk owner readies for big Wegovy windfall
